Function and Dysfunction of the Caveolar Network in Cell Signaling and Human Disease: An Update after 70 Years of the Discovery of Caveolae

Dear Colleagues,

Caveolae (i.e., 50 to 80 nm cholesterol- and glycosphingolipid-rich, flask-shaped invaginations discovered nearly 70 years ago) have been observed in many differentiated cells. Unlike lipid rafts, whose existence remains quite elusive in living cells, caveolae are ordinarily detectable via conventional electron microscopy techniques. The unique biochemical composition of caveolae confers on them a marked resistance to solubilization by nonionic detergent, which permits the separation of these organelles from the rest of the cellular components. However, only following the discovery of the first genuine molecular marker of caveolae, i.e., caveolin-1 in the early 1990s, has the research in this field grown rapidly. Caveolin-1, encoded by the CAV gene family, is usually found coexpressed with caveolin-2 in the majority of the cell types, while the third member of the family, caveolin-3, is predominantly expressed in striated muscle cells. The ability of the caveolin scaffolding proteins to interact with a variety of signaling molecules has strongly encouraged many groups to focus on these fascinating and enigmatic structures. More than 60 years of investigation on the caveolar membrane system have strongly contributed to extending and enhancing our knowledge of the crucial cellular mechanisms, including vesicular transport, endocytosis, cholesterol homeostasis, signal transduction, cell metabolism, and cancer.  However, although the generation of caveolin knockout animals has strongly contributed to deepening the biological role of the caveolar network in vivo, many issues related to the mechanisms regulated by caveolins, both under physiological and pathological conditions, remain open. The aim of this Special Issue is to gather up-to-date results that may expand our knowledge around the multifaceted role of caveolae and caveolin proteins in cell dysfunction and human diseases. Both research and review articles related to the current state of the art in this field are also welcome.

Prof. Dr. Alessio D'Alessio
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cancer
• caveolae
• caveolin
• cavins
• cell metabolism
• endocytosis
• hypertension
• lipid homeostasis
• lipid rafts
• lipodystrophy
• mechanobiology
• caveolinopathies
• muscular dystrophy